Tianjing Li is an Associate Professor in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health (JHBSPH) and currently based at University of Colorado Denver. Dr Li was trained as a physician and subsequently earned her PhD in Epidemiology (Clinical Trials concentration) and MHS in Biostatistics from JHBSPH. The primary goal of Dr Li's research is to develop, evaluate, and disseminate efficient methods for comparing healthcare interventions and to provide trustworthy evidence for decision making. Her core research interests include methodologies for randomized controlled trials, systematic reviews, network meta-analysis, comparative effectiveness research, and patient-centered outcomes research. Dr Li serves as the Associate Director for Cochrane United States and the Director for Research for Cochrane Eyes and Vision US Project.
Tianjing Li, Editor-in-Chief
Follow
Annual Journal Metrics
-
Citation Impact
2.728 - 2-year Impact Factor (2021)
2.754 - 5-year Impact Factor (2021)
0.930 - Source Normalized Impact per Paper (SNIP)
1.067 - SCImago Journal Rank (SJR)Speed
69 days to first decision for all manuscripts (Median)
110 days to first decision for reviewed manuscripts only (Median)Usage
6,130,958 Downloads (2022)
7,557 Altmetric mentions (2021)